Want to see AU:MVF full AI Analyst Report?
MVF Stock Chart & Stats
AU$0.69
AU$0.03(4.58%)
At close: 4:00 PM EDT
AU$0.69
AU$0.03(4.58%)
Day’s Range― - ―
52-Week RangeAU$0.58 - AU$0.90
Previous CloseN/A
Volume457.94K
Average Volume (3M)772.56K
Market Cap
AU$278.59M
Enterprise ValueAU$477.57M
Total Cash (Recent Filing)AU$8.84M
Total Debt (Recent Filing)AU$199.62M
Price to Earnings (P/E)37.4
Beta1.16
Next Earnings
Feb 25, 2027EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend Yield3.5%
Share Statistics
EPS (TTM)0.02
Shares Outstanding389,634,830
10 Day Avg. Volume1,443,708
30 Day Avg. Volume772,562
Financial Highlights & Ratios
PEG Ratio-0.54
Price to Book (P/B)1.13
Price to Sales (P/S)1.05
P/FCF Ratio38.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.78Price Target Upside12.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$280.80M
Bulls Say, Bears Say
Bulls Say
Integrated Fertility Care ModelMVF combines clinical treatment, laboratory work and diagnostics within a single fertility-care pathway. This integrated model can support patient continuity, capture more services per treatment journey, and reinforce the value of its clinic and specialist infrastructure over the medium term.
Long-term Revenue GrowthAlthough recent growth has moderated, revenue has expanded across the broader period, showing that MVF retains an established base of patient demand and operating scale. Continued growth from that platform could support investment in clinics, laboratories and reproductive-care capabilities.
Meaningful Equity BaseMVF has a substantial equity base relative to its asset base, providing financial resources that can support ongoing operations and strategic investment. This capital cushion is an important stabilising feature even as the company manages higher debt and weaker recent returns.
Bears Say
Sharp Margin CompressionThe steep decline in gross and net margins indicates materially weaker earnings conversion from revenue. If margins remain near current levels, MVF may have less capacity to fund expansion, absorb operating volatility, or translate stable patient demand into durable profit growth.
Materially Higher LeverageThe substantial rise in debt relative to equity reduces financial flexibility and increases the importance of consistent operating performance. Higher leverage can constrain capital allocation and leave MVF less able to withstand prolonged margin pressure or weaker treatment volumes.
Weak And Inconsistent Free Cash FlowLow free-cash-flow conversion means reported earnings are currently producing limited discretionary cash for debt reduction, reinvestment or shareholder returns. The uneven cash record adds uncertainty to funding capacity and makes the business more dependent on improving profitability and conversion.
Monash IVF Group Ltd News
MVF FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest share price was AU$0.57 and its highest was AU$0.90 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is AU$278.59M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Feb 25, 2027 which is in 124 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Monash IVF Group Ltd released its earnings results on Aug 30, 2026. The company reported AU$0.014 earnings per share for the quarter, missing the consensus estimate of AU$0.022 by -AU$0.008.
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd pays a Semiannually dividend of AU$0.013 which represents an annual dividend yield of 3.5%. See more information on Monash IVF Group Ltd dividends here
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate is 0.03.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Monash IVF Group Ltd reported an EPS of AU$0.014 in its last earnings report, missing expectations of AU$0.022. Following the earnings report the stock price went up 2.853%.
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in AU:MVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.78 (12.32% Upside)
AU$0.78 (12.32% Upside)
Blogger Sentiment
Bullish
AU:MVF Sentiment 100%
Sector Average 66%
Sector Average 66%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
5.14%
12-Months-Change
Fundamentals
Return on Equity
2.95%
Trailing 12-Months
Asset Growth
4.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Monash IVF Group Ltd
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
MVF Stock 12 Month Forecast
Average Price Target
AU$0.78
▲(12.32% Upside)
Technical Analysis
―
Healius Limited
―
Cryosite Limited
―
Sonic Healthcare Limited
―
Australian Clinical Labs Ltd
―